HDAC ‐inhibitor (S)‐8 disrupts HDAC 6‐ PP 1 complex prompting A375 melanoma cell growth arrest and apoptosis-Reference-Cited by-同舟云学术

HDAC ‐inhibitor (S)‐8 disrupts HDAC 6‐ PP 1 complex prompting A375 melanoma cell growth arrest and apoptosis

Published:2014-11-06 Issue:1 Volume:19 Page:143-154
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J. Cell. Mol. Med.

Author:

Balliu Manjola¹,Guandalini Luca²,Romanelli Maria Novella²,D'Amico Massimo³,Paoletti Francesco³

Affiliation:

1. Department of Experimental and Clinical Medicine University of Florence Firenze Italy

2. NEUROFARBA ‐ Department of Neurosciences, Psychology, Drug Research and Child Health Section of Pharmaceutical and Nutracetical Sciences University of Florence Firenze Italy

3. Department of Biomedical Experimental and Clinical Sciences Section of Experimental Pathology and Oncology University of Florence Firenze Italy

Funder

AIRC 5 per Mille to AGIMM AIRC-Gruppo Italiano Malattie Mieloproliferative

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.12345

Reference42 articles.

1. Histone deacetylases and cancer: causes and therapies

2. Histone acetylases and deacetylases in cell proliferation

3. Histone deacetylase inhibitors

4. Anticancer activities of histone deacetylase inhibitors

5. Histone deacetylase inhibitors: Potential in cancer therapy

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HDAC6 mediates tumorigenesis during mitosis and the development of targeted deactivating agents;Bioorganic Chemistry;2024-09

2. Targeting histone deacetylase suppresses tumor growth through eliciting METTL14‐modified m⁶A RNA methylation in ocular melanoma;Cancer Communications;2023-07-19

3. Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises;Pharmacology & Therapeutics;2022-12

4. Etiology of non-Hodgkin lymphoma: A review from epidemiologic studies;Journal of the National Cancer Center;2022-12

5. The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy;Journal of the National Cancer Center;2022-12